Physician profile
Timothy J Quillen
NPI 1619922879
$6,293.25
in general payments reported to CMS, 2019-2025
40 companies · $607 in 2025
The $607 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,262 · 2020: $333 · 2021: $778 · 2022: $543 · 2023: $954 · 2024: $817 · 2025: $607.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,278 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,278.09 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $1,445.24 | 2019 | |
| Astellas Pharma US INC | $700.25 | 2019-2023 | Myrbetriq |
| Teleflex LLC | $616.36 | 2021-2025 | Urolift, Barrigel |
| Abbvie INC. | $533.52 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $381.36 | 2023-2025 | Orgovyx, Gemtesa |
| Coloplast Corp | $379.50 | 2019-2024 | Speedicath, Porges Coloplast |
| Myriad Genetic Laboratories, INC. | $289.17 | 2020-2025 | Prolaris, Precisetumor |
| Antares Pharma, INC. | $254.88 | 2019-2023 | Tlando, Xyosted, Nocdurna |
| Janssen Biotech, INC. | $243.56 | 2022-2025 | Erleada |
| Boston Scientific Corporation | $215.42 | 2019-2025 | Rezum Generator, Spaceoar Vue System - 10ml |
| Dendreon Pharmaceuticals LLC | $172.30 | 2019-2024 | Provenge |
| Srs Medical Systems, INC. | $113.73 | 2023 | Urocuff |
| Procept Biorobotics Corporation | $102.98 | 2023-2025 | Aquabeam Robotic System |
| Endo Pharmaceuticals INC. | $92.01 | 2019-2022 | |
| Olympus America INC. | $85.30 | 2023-2025 | Itind System |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Quillen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.